Renal Research Institute, New York, New York, USA.
Kidney Int. 2010 Aug;78(4):343-50. doi: 10.1038/ki.2010.157. Epub 2010 Jun 2.
The recently published KDIGO (Kidney Disease: Improvement of Global Outcomes) guideline (GL) for dialysate calcium suggests a narrow range of dialysate inlet calcium concentrations (C(di)Ca(++)) of 2.50-3.00 mEq/l. The work group's primary arguments supporting the GL were (1) there is a negligible flux of body Ca(++) during dialysis and (2) C(di)Ca(++) of 2.50 mEq/l will generally result in neutral Ca(++) mass balance (Ca(MB)). We believe we have shown that both of these arguments are incorrect. Kinetic modeling and analysis of dialyzer Ca(++) transport during dialysis (J(d)Ca(++)) demonstrates that more than 500 mg of Ca can be transferred during a single dialysis and that on average 76% of this Ca flux is from the miscible calcium pool rather than plasma pool. Kinetic modeling of intestinal calcium absorption (Ca(Abs)) shows a strong dependence of Ca(Abs) on the dose of vitamin D analogs and weaker dependence on the level of Ca intake (Ca(INT)). We used the Ca(Abs) model to calculate Ca(Abs) as a function of total Ca(INT) and prescribed doses of vitamin D analogs in 320 hemodialysis patients. We then calculated total dialyzer calcium removal (TJ(d)Ca(++)) and the C(di)Ca(++) that would be required to achieve TJ(d)Ca(++)=Ca(Abs), that is, Ca(MB)=0 over the whole dialysis cycle (that is, covering both the intra- and the inter-dialytic period). The results indicate that 70% of patients on Ca-based binders and 20-50% of patients on non-Ca-based binders would require C(di)Ca(++) <2.50 mEq/l to prevent long-term Ca accumulation.
最近发布的 KDIGO(肾脏疾病:改善全球结局)指南(GL)建议透析液钙的入口钙浓度(C(di)Ca(++)) 应保持在 2.50-3.00mEq/l 的狭窄范围内。工作组支持 GL 的主要论点是:(1)在透析过程中,体内 Ca(++) 的通量可以忽略不计;(2)C(di)Ca(++)) 为 2.50mEq/l 通常会导致中性 Ca(++) 质量平衡(Ca(MB))。我们认为,我们已经证明这两个论点都是不正确的。在透析过程中,通过动力学建模和分析透析器 Ca(++) 转运(J(d)Ca(++)),我们发现单次透析过程中可以转移超过 500mg 的 Ca,并且平均 76%的 Ca 通量来自可混合钙池,而不是血浆池。肠道钙吸收(Ca(Abs))的动力学建模表明,Ca(Abs) 强烈依赖于维生素 D 类似物的剂量,而对钙摄入量(Ca(INT))的依赖性较弱。我们使用 Ca(Abs) 模型,根据 320 名血液透析患者的总 Ca(INT)和维生素 D 类似物的处方剂量,计算 Ca(Abs)。然后,我们计算了总透析器钙清除(TJ(d)Ca(++)) 和需要达到 TJ(d)Ca(++)=Ca(Abs)的透析液钙浓度(C(di)Ca(++)),即整个透析周期(包括透析间期和透析期)的 Ca(MB)=0。结果表明,70%使用 Ca 基结合剂的患者和 20-50%使用非 Ca 基结合剂的患者需要 C(di)Ca(++)<2.50mEq/l 以防止长期 Ca 积累。